Shire Plc : * Shire update re: AbbVie proposal* Announces that following discussions with AbbVie Inc, Shire requested and has received a further revised proposal from AbbVie on 13 July 2014* Under revised proposal, Shire shareholders would own approximately 25 per cent of combined new AbbVie.* Revised proposal comprises �24.44 in cash and 0.8960 shares of new AbbVie per shire share
AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. Shares of ABBV fell by 0.74% or $-0.41/share to $54.96. In the past year, the shares have traded as low as $42.25 and as high as $58.27. On average, 5832730 shares of ABBV exchange hands on a given day and today's volume is recorded at 13593033.
Source
